...
首页> 外文期刊>International heart journal >Neutrophil to Lymphocyte Ratio Predicts SYNTAX Score in Patients With Non-ST Segment Elevation Myocardial Infarction
【24h】

Neutrophil to Lymphocyte Ratio Predicts SYNTAX Score in Patients With Non-ST Segment Elevation Myocardial Infarction

机译:中性粒细胞与淋巴细胞的比例预测非ST段抬高型心肌梗死患者的SYNTAX评分

获取原文
获取原文并翻译 | 示例
           

摘要

In this study we aimed to investigate whether there is an association between the neutrophil to lymphocyte ratio (NLR) and severity of coronary artery disease (CAD) in patients with non-ST segment elevation myocardial infarction (NSTEMI) using the SYNTAX score (SXscore). A total of 414 patients with NSTEMI who underwent coronary angiography were enrolled in the study. NLR was measured for all patients at presentation. The study population was then divided into 3 tertiles based on the SYNTAX trial results.(I)) The low syntax group (n = 329) was defined as those with an SXscore <= 22, the intermediate syntax group (n = 58) was defined as an SXscore >= 23 and < 33, and the high syntax group (n = 27) as those with an SXscore >= 33. NLR was significantly lower in patients with a low SXscore compared to patients with an intermediate SXscore or high SXscore (3.7 +/- 4 to 4.6 +/- 2 and 7.9 +/- 4, P < 0.001). Linear regression analysis revealed that NLR (coefficient beta = 0.380, 95%CI: 1.165-1.917, P < 0.001) was significantly associated with the SXscore in patients with NSTEMI. Our results indicate that NLR is independently associated with the severity of CAD in patients with NSTEMI.
机译:在这项研究中,我们旨在使用SYNTAX评分(SXscore)调查非ST段抬高型心肌梗死(NSTEMI)患者的中性粒细胞与淋巴细胞之比(NLR)与冠状动脉疾病严重程度(CAD)之间是否存在关联。该研究共纳入414例接受冠状动脉造影的NSTEMI患者。就诊时对所有患者进行NLR测量。然后根据SYNTAX试验结果将研究人群分为3个三分位数。(I))低语法组(n = 329)定义为SXscore <= 22的那些,中级语法组(n = 58)为定义为SXscore> = 23和<33,高语法组(n = 27)定义为SXscore> =33。SXscore低的患者与SXscore中度或SXscore高的患者相比,NLR显着降低(3.7 +/- 4至4.6 +/- 2和7.9 +/- 4,P <0.001)。线性回归分析显示,NSTEMI患者的NLR(系数β= 0.380,95%CI:1.165-1.917,P <0.001)与SXscore显着相关。我们的结果表明,NSTEMI患者中NLR与CAD的严重程度独立相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号